PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-8

  1. 6,008 Posts.
    lightbulb Created with Sketch. 1153
    yeah, delays to the start of part II for sure... but, with a lot more sites open, along with no doubt still screening patients for it while waiting for optimal dosage, they could very well still catch up... hopefully big numbers ready for jab early Qtr 1 24.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.